The Role of Immunotherapy in Non-transplant Eligible Multiple Myeloma.

MLA

Bobin, Arthur, et al. “The Role of Immunotherapy in Non-Transplant Eligible Multiple Myeloma.” Frontiers in Oncology, vol. 10, May 2020, p. 676. EBSCOhost, https://doi.org/10.3389/fonc.2020.00676.

APA

Bobin, A., Gardeney, H., Sabirou, F., Gruchet, C., Lévy, A., Nsiala, L., Cailly, L., Tomowiak, C., Torregrosa, J., Guidez, S., & Leleu, X. (2020). The Role of Immunotherapy in Non-transplant Eligible Multiple Myeloma. Frontiers in Oncology, 10, 676. https://doi.org/10.3389/fonc.2020.00676

Chicago

Bobin, Arthur, Hélène Gardeney, Florence Sabirou, Cécile Gruchet, Anthony Lévy, Laly Nsiala, Laura Cailly, et al. 2020. “The Role of Immunotherapy in Non-Transplant Eligible Multiple Myeloma.” Frontiers in Oncology 10 (May): 676. doi:10.3389/fonc.2020.00676.